MRNA News and Press, Moderna Inc. From 02/17/26

2026-02-17 07:15:07 ET Bernstein analyst issues MARKET PERFORM recommendation for MRNA on February 17, 2026 12:04PM ET. The previous analyst recommendation was Market Perform. MRNA was trading at $42.23 at issue of the analyst recommendation. The overall analyst consensu...

mNEXSPIKE is the third Moderna vaccine authorized in the European Union, strengthening the Company's respiratory vaccine portfolio in Europe CAMBRIDGE, MA / ACCESS Newswire / February 17, 2026 / Moderna, Inc. (NASDAQ:MRNA) today announced that the European Commission (EC) has granted mark...

2026-02-16 08:04:08 ET from UBS issued a price target of $36.00 for MRNA on 2026-02-16 12:52:39. The adjusted price target was set to $36.00. At the time of the announcement, MRNA was trading at $42.23. The overall price target consensus is at $30.00 with high price of $...

2026-02-16 08:04:07 ET from Morgan Stanley issued a price target of $30.00 for MRNA on 2026-02-16 12:47:11. The adjusted price target was set to $30.00. At the time of the announcement, MRNA was trading at $42.23. The overall price target consensus is at $30.00 with high...

2026-02-14 13:20:23 ET Let’s take a look at some of the companies that reported earnings this week: Moderna ( MRNA ) topped Q4 estimates and reaffirmed its 2026 growth target even as the vaccine maker suffered a major regulatory setback for its flu shot candidate ...

2026-02-14 11:20:40 ET More on Pfizer, Moderna, etc. Moderna, Inc. (MRNA) Q4 2025 Earnings Call Transcript Moderna, Inc. 2025 Q4 - Results - Earnings Call Presentation Pfizer: A Great Opportunity Post Earnings Earnings Scorecard: Healthcare sector shows stron...

2026-02-14 11:20:22 ET More on markets January CPI Inflation: Yet Another Stock Market Positive Goldilocks Data To Be Challenged Next Week: The Preview For GDP And PCE Inflation Reports CPI Marches Toward 2% But Non-Tariff Hurdles Remain SA Analyst says value...

2026-02-14 10:45:32 ET More on Healthcare Moderna, Inc. (MRNA) Q4 2025 Earnings Call Transcript Medtronic: Navigating Tariffs And Chinese VBP Challenges Moderna, Inc. 2025 Q4 - Results - Earnings Call Presentation Moderna outlines up to 10% revenue growth for...

2026-02-13 14:01:58 ET More on pharmaceuticals, biotech Big Pharma's Earnings Week: Strong Performance, Obesity Wars, LOE Management And More BBH: Mature Biotech Exposure, But Limited Growth Ahead XPH: Healthcare Dashboard For January Most and least shorted m...

2026-02-13 12:48:45 ET More on Moderna Moderna, Inc. (MRNA) Q4 2025 Earnings Call Transcript Moderna, Inc. 2025 Q4 - Results - Earnings Call Presentation Moderna: FDA RTF Derails mRNA-1010 And Reignites The Sell Case Moderna reaffirms 2026 growth outlook desp...